Compound class:
Synthetic organic
Comment: LPC-233 is an orally bioavailable preclinical antibacterial compound that inhibits bacterial UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) and has potent activity against a wide range of Gram-negative bacteria in vitro [5].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-(4-cyclopropylbuta-1,3-diynyl)-N-[(2S,3S)-4,4-difluoro-3-hydroxy-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl]benzamide |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
LPC-233 |
Other databases | |
CAS Registry No. | 2142075-09-8 (source: Scifinder) |
GtoPdb PubChem SID | 507750457 |
PubChem CID | 132060142 |
RCSB PDB Ligand | UFX |
Search Google for chemical match using the InChIKey | NPTNDHDCCLLFJE-BEFAXECRSA-N |
Search Google for chemicals with the same backbone | NPTNDHDCCLLFJE |
UniChem Compound Search for chemical match using the InChIKey | NPTNDHDCCLLFJE-BEFAXECRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NPTNDHDCCLLFJE-BEFAXECRSA-N |